Editor
People residing with one of the vital frequent forms of alopecia might quickly have entry to therapy on the NHS in Scotland for the primary time.
The drug – referred to as Ritlecitinib – will go earlier than the Scottish Medicines Consortium this week after it was accredited for NHS use in England final month.
Although the every day capsule received’t remedy the situation, it might present therapy to some who’ve extreme alopecia areata, like 21-year-old Megan McCready, from Clydebank.
Since her prognosis on the age of 12, Megan has realized to embrace her situation and now helps different younger folks going via the identical factor.
Video by Morgan Spence and Hazel Martin
